162 related articles for article (PubMed ID: 35509952)
21. Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
Dominguez M; Perez JA; Patel CB
Methodist Debakey Cardiovasc J; 2013; 9(1):49-53. PubMed ID: 23519387
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hyponatremia in children with gastroenteritis treated with hypotonic intravenous fluids.
Hanna M; Saberi MS
Pediatr Nephrol; 2010 Aug; 25(8):1471-5. PubMed ID: 20108002
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
24. NaCl 3% Bolus Therapy as Emergency Treatment for Severe Hyponatremia: Comparison of 100 mL vs 250 mL.
Massop K; Haverkort DA; Bech AP; de Boer H
J Clin Endocrinol Metab; 2023 Jul; 108(8):e521-e526. PubMed ID: 36808420
[TBL] [Abstract][Full Text] [Related]
25. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
Gankam Kengne F; Couturier BS; Soupart A; Decaux G
Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
[TBL] [Abstract][Full Text] [Related]
26. Serum sodium correction rate and the outcome in severe hyponatremia.
Giordano M; Ciarambino T; Priore EL; Castellino P; Malatino L; Cataliotti A; Paolisso G; Adinolfi LE
Am J Emerg Med; 2017 Nov; 35(11):1691-1694. PubMed ID: 28600073
[TBL] [Abstract][Full Text] [Related]
27. Hypertonic saline: patterns of and guidelines for use.
Culpepper RM; Clements BD; Pence SR
South Med J; 1994 Dec; 87(12):1203-7. PubMed ID: 7973918
[TBL] [Abstract][Full Text] [Related]
28. Hyponatremia in ICU.
Pillai KS; Trivedi TH; Moulick ND
J Assoc Physicians India; 2018 May; 66(5):48-52. PubMed ID: 30477055
[TBL] [Abstract][Full Text] [Related]
29. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.
Ayus JC; Olivero JJ; Frommer JP
Am J Med; 1982 Jan; 72(1):43-8. PubMed ID: 7058821
[TBL] [Abstract][Full Text] [Related]
30. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.
Rondon-Berrios H; Sterns RH
Am J Kidney Dis; 2022 Jun; 79(6):890-896. PubMed ID: 34508830
[TBL] [Abstract][Full Text] [Related]
31. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Serum Sodium Correction Rates for Management of Hyponatremia in Hospitalized Patients.
Pham CT; Kassab HS; Johnston JP
Ann Pharmacother; 2022 Feb; 56(2):131-138. PubMed ID: 34027713
[TBL] [Abstract][Full Text] [Related]
33. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
[TBL] [Abstract][Full Text] [Related]
34. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Rudolf D; Salahudeen A; Verbalis J; Grohé C
Support Care Cancer; 2017 Jul; 25(7):2275-2283. PubMed ID: 28255808
[TBL] [Abstract][Full Text] [Related]
35. Hypertonic saline resuscitation: efficacy in a community-based burn unit.
Griswold JA; Anglin BL; Love RT; Scott-Conner C
South Med J; 1991 Jun; 84(6):692-6. PubMed ID: 2052955
[TBL] [Abstract][Full Text] [Related]
36. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
37. Current treatment practice and outcomes. Report of the hyponatremia registry.
Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of severe hyponatremia (<120mEq/l)].
Decaux G
Rev Med Brux; 2001 Oct; 22(5):413-9. PubMed ID: 11723783
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial.
Yang H; Yoon S; Kim EJ; Seo JW; Koo JR; Oh YK; Jo YH; Kim S; Baek SH
Kidney Res Clin Pract; 2022 May; 41(3):298-309. PubMed ID: 35286796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
